News
Revisiting hormone control of glucose – keep your enemies close (Jennifer Estall, IRCM)
27 June 2019
General Public News
Dr. Jennifer Estall received her Ph.D. from the University of Toronto, followed by a postdoctoral fellowship at Harvard Medical School. She is currently an Associate Research Professor at the Montreal Clinical Research Institute (IRCM), and also holds academic affiliations to the University of Montreal and McGill University. Her research interests encompass early molecular mechanisms in the pathogenesis of metabolic disease, with focus on transcriptional regulators and energy metabolism.
Her current research centers on how islet cell metabolism impacts endocrine function and cell survival, molecular pathways altering metabolism in fatty liver disease, and how mitochondrial dysfunction impacts diabetes through organ crosstalk.
Here are some French public links for Jennifer Estall’s research team:
- Étude sur le diabète: les bienfaits du glucagon (LaPresse, 2019) :
- Le glucagon, un ennemi devenu un allié contre le diabète (Radio-Canada, 2019) :
https://ici.radio-canada.ca/nouvelle/1158396/diabete-insuline-glucagon-hormones-ircm
- Contrôle du diabète : le glucagon, un allié de l’insuline (FRSQ, 2019) :
http://www.frqs.gouv.qc.ca/la-recherche/la-recherche-en-vedette/histoire?id=2rqve45y1560260411201
- La faible place des femmes dans l’écriture des sciences influence les résultats (SciencePresse, 2019) :
- Une recherche prometteuse pour soigner le diabète chez les femmes (Metro, 2016) :
- Une protéine permettrait de prédire le diabète (Metro, 2014) :
https://journalmetro.com/plus/sante/431315/une-proteine-permettrait-de-predire-le-diabete/
- Café scientifique – Type 1 Diabetes: Toward a Needle-free future (Youtube, 2012) :
